Swedish stent maker Jomed plans market listing:
This article was originally published in Clinica
Executive Summary
Jomed, a Swedish manufacturer of cardiac minimally-invasive devices, plans a stock market listing by 2000 that could value the company at up to Euro800 million ($862 million). It is believed the Helsingborg-based group will list in Frankfurt rather than Stockholm. In 1998, the company's sales grew by 68% to Euro25.5 million, while profits almost tripled to Euro6.1 million. Jomed has expanded rapidly since its launch in the early 1990s, reflecting the corresponding growth in minimally-invasive surgery in the hospital sector.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.